Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE6474.50301.8 (+4.89 %)
PREV CLOSE ( ) 6172.70
OPEN PRICE ( ) 6233.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 6474.50 (289)
VOLUME 51042
TODAY'S LOW / HIGH ( )6121.10 6775.80
52 WK LOW / HIGH ( )4941.7 7077.7
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
30Jan Divis Laboratories informs about board
Divis Laboratories has informed that the meeting of the Board of Directo..
03Jan Divi's Laboratories informs about cert
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
31Dec Divi’s Laboratories informs about cl
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Rep..
10Nov Divi's Laboratories reports 35% rise i
Divi's Laboratories has reported result for second quarter ended Septemb..
12Aug Divi's Laboratories informs about tran
Divi's Laboratories has submitted the transcript of the earnings confere..
MORE
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit598022090
Gross Profit 7980 29290
Operating Profit 994033310
Net Sales 2578091980
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
up  5201.35 (4.76%)
M.Cap ( in Cr)23795.00
Astrazeneca Pharma I (BSE)
up  9070.80 (1.30%)
M.Cap ( in Cr)22677.00
Fredun Pharma (BSE)
up  1882.50 (5.59%)
M.Cap ( in Cr)1010.15
Glaxosmithkline Phar (BSE)
up  2700.80 (3.09%)
M.Cap ( in Cr)45753.18
Alkem Laboratories (BSE)
up  5887.85 (1.28%)
M.Cap ( in Cr)70398.08
MORE
Shareholding Pattern
NON-INSTITUTION 8.76%
PROMOTERS 51.88%
FI/BANKS/INSURANCE 4.96%
MUTUAL FUNDS/UTI 13.73%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

  • Cameo Corporate Services Limited
  • #1, Subramanian Building,
  • Club House Road, Chennai-600002.
  • Contact No : 044-40020731
Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Limited. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.